Post-approval studies (Phase 4)Ended earlyNCT06042920
What this trial is testing
Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
Who this might be right for
Palmoplantar PsoriasisGenital Psoriasis
Bristol-Myers Squibb 130